Precision Medicine acquires Project Farma

By The Science Advisory Board staff writers

January 15, 2021 -- Precision Medicine has acquired Project Farma, a bioengineering services firm.

Project Farma has led more than a dozen manufacturing facility builds with capital investments greater than $1 billion. The company has been involved in the development of several cell and gene therapy medicines.

The firm will be part of Precision for Medicine, Precision Medicine's research and development services arm.

Copyright © 2021

Laboratory Products Association Annual Meeting
October 1-4
Scottsdale, Arizona United States
Cell & Gene Meeting on the Mesa
October 11-13
Carlsbad, California United States
IDWeek 2022
October 19-23
District of Columbia United States
American Society of Human Genetics Annual Meeting
October 25-29
Los Angeles, California United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter